Hoth Therapeutics Stock Investor Sentiment

HOTH Stock  USD 0.85  0.01  1.16%   
Under 61% of Hoth Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Hoth Therapeutics stock suggests that many investors are alarmed at this time. Hoth Therapeutics' investing sentiment shows overall attitude of investors towards Hoth Therapeutics.
  

Hoth Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Hoth Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at news.google.com         
Hoth Therapeutics amends bylaws to clarify shareholder voting rights - Investing.com
Google News at Macroaxis
over six months ago at seekingalpha.com         
Hoth Therapeutics announces JD with Wise Systems International
seekingalpha News
over six months ago at gizmodo.com         
Hans in Carbonite, Ranked
news
over six months ago at news.google.com         
Diamond Equity Research Emerging Growth Invitational Winter 2021 Virtual Conference - The Globe and ...
Google News at Macroaxis
over six months ago at www.macroaxis.com         
Acquisition by Sarnoff David of 7500 shares of Hoth Therapeutics at 2.59 subject to Rule 16b-3
Macroaxis News
over six months ago at news.google.com         
Is WBD Stock a Buy 3 Analysts Weigh In on Warner Bros. Discovery. - The Globe and Mail
Google News at Macroaxis
over six months ago at news.google.com         
Hoth Therapeutics and Algorithm Sciences Terminate Letter of Intent to Merge - The Globe and Mail
Google News at Macroaxis
over six months ago at investorplace.com         
HOTH Stock Earnings Hoth Therapeutics Misses EPS for Q1 2024
sbwire news
over six months ago at news.google.com         
Were Keeping An Eye On Hoth Therapeutics Cash Burn Rate - Yahoo News UK
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
Yahoo News
over six months ago at gizmodo.com         
These Star Wars Toy Photos Are as Special as the Toys Themselves
news
over six months ago at seekingalpha.com         
Hoth Therapeutics files to sell 5.03M shares of common stock for holders
seekingalpha News
over six months ago at news.google.com         
Analysts Offer Predictions for Hoth Therapeutics, Inc.s Q1 2024 Earnings - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Hoth Therapeutics Buy Rating Reiterated at HC Wainwright - Defense World
Google News at Macroaxis
over six months ago at gizmodo.com         
How Star Tours Laid the Stage for Disneys Galactic Ambitions
news
Far too much social signal, news, headlines, and media speculation about Hoth Therapeutics that are available to investors today. That information is available publicly through Hoth media outlets and privately through word of mouth or via Hoth internal channels. However, regardless of the origin, that massive amount of Hoth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Hoth Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Hoth Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Hoth Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Hoth Therapeutics alpha.

Hoth Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Hoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment Stu...
10/29/2024
2
Hoth Therapeutics Receives Buy Rating from HC Wainwright
11/04/2024
3
Acquisition by Poor Kevin Jess of 750000 shares of Hoth Therapeutics subject to Rule 16b-3
11/27/2024

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators